Target intelligence / Profile preview

SND1 intronic transcript 1 (SND1-IT1)

Target
SND1-IT1
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

SND1 intronic transcript 1 (SND1-IT1) is a long non-coding RNA (lncRNA) transcribed from the intronic region of the SND1 gene, also referred to by aliases such as NAG8, NSG-X, and C7orf54[5][6]. SND1-IT1 is non-protein coding and has drawn attention for its possible roles in cancer biology, particularly in nasopharyngeal carcinoma and gastric cancer. It is reported to enhance the malignant transformation of gastric mucosa cells by up-regulating SNAIL1, implicating it in epithelial-mesenchymal transition and cancer progression[5]. While it is not a direct therapeutic target such as an enzyme or receptor, SND1-IT1 is considered for its disease association potential, especially as a biomarker or a modulator in oncogenesis. The molecular classification as a lncRNA distinguishes SND1-IT1 from protein-coding targets, and there is currently insufficient evidence for direct small-molecule drug interactions or established mechanisms of action.

Other names
NAG8NSG-XC7orf54nasopharyngeal carcinoma associated gene protein-8Brain and nasopharyngeal carcinoma susceptibility protein NSG-xnasopharyngeal carcinoma-associated gene 8 proteinSND1 intronic transcript 1 (non-protein coding)brain and nasopharyngeal carcinoma susceptibilitynasopharyngeal carcinoma associated gene 8
02

Biological functions

Regulation of gene expressionModulation of malignant transformation in cancerOther
03

Disease associations

CancerSpecifically associated with gastric cancer and nasopharyngeal carcinoma
04

Biomarkers

Potential biomarker for nasopharyngeal carcinoma susceptibility (based on name association and disease linkage)Potential biomarker and functional player in gastric cancer (limited evidence)

Beyond the preview

Go deeper on SND1 intronic transcript 1 (SND1-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SND1 intronic transcript 1 (SND1-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call